OBJECTIVES: We assessed the willingness of gay and bisexual men, who have high rates of anal cancer that might be prevented through regular screening, to receive anal Papanicolaou tests. METHODS: We surveyed a national sample of men aged 18 to 59 years who self-identified as gay (n = 236) or bisexual (n = 70). RESULTS: Most respondents were willing to accept free screening (83%), but fewer would pay for the test (31%; McNemar's chi(2) = 158.02; P < .001). Willingness to pay for screening was higher among men who reported greater worry about getting anal cancer (OR [odds ratio] = 1.70; 95% confidence interval [CI] = 1.06, 2.72), higher perceived likelihood of anal cancer (OR = 1.88; 95% CI = 1.18, 2.99), and higher income (OR = 2.17; 95% CI = 1.18, 3.98), in adjusted analyses. Only 33% (17 of 51) of HIV-positive respondents, who have the highest risk for anal cancer, had received anal Papanicolaou tests. CONCLUSIONS: Anal cancer screening was highly acceptable to gay and bisexual men, although cost was a major barrier. Efforts to reduce anal cancer disparities should target beliefs about anal cancer and barriers to anal Papanicolaou testing in this population.
OBJECTIVES: We assessed the willingness of gay and bisexual men, who have high rates of anal cancer that might be prevented through regular screening, to receive anal Papanicolaou tests. METHODS: We surveyed a national sample of men aged 18 to 59 years who self-identified as gay (n = 236) or bisexual (n = 70). RESULTS: Most respondents were willing to accept free screening (83%), but fewer would pay for the test (31%; McNemar's chi(2) = 158.02; P < .001). Willingness to pay for screening was higher among men who reported greater worry about getting anal cancer (OR [odds ratio] = 1.70; 95% confidence interval [CI] = 1.06, 2.72), higher perceived likelihood of anal cancer (OR = 1.88; 95% CI = 1.18, 2.99), and higher income (OR = 2.17; 95% CI = 1.18, 3.98), in adjusted analyses. Only 33% (17 of 51) of HIV-positive respondents, who have the highest risk for anal cancer, had received anal Papanicolaou tests. CONCLUSIONS:Anal cancer screening was highly acceptable to gay and bisexual men, although cost was a major barrier. Efforts to reduce anal cancer disparities should target beliefs about anal cancer and barriers to anal Papanicolaou testing in this population.
Authors: Paul L Reiter; Noel T Brewer; Sami L Gottlieb; Annie-Laurie McRee; Jennifer S Smith Journal: Soc Sci Med Date: 2009-06-18 Impact factor: 4.634
Authors: Carey V Johnson; Matthew J Mimiaga; Sari L Reisner; Ashley M Tetu; Kevin Cranston; Thomas Bertrand; David S Novak; Kenneth H Mayer Journal: Am J Public Health Date: 2009-02-12 Impact factor: 9.308
Authors: Gina Shetty; Julian A Sanchez; Johnathan M Lancaster; Lauren E Wilson; Gwendolyn P Quinn; Matthew B Schabath Journal: Patient Educ Couns Date: 2016-05-02
Authors: L Cattelan; F M Ghazawi; M Le; E Savin; A Zubarev; F Lagacé; D Sasseville; K Waschke; I V Litvinov Journal: Curr Oncol Date: 2020-06-01 Impact factor: 3.677
Authors: Matthew B Schabath; Catherine A Blackburn; Megan E Sutter; Peter A Kanetsky; Susan T Vadaparampil; Vani N Simmons; Julian A Sanchez; Steven K Sutton; Gwendolyn P Quinn Journal: J Clin Oncol Date: 2019-01-16 Impact factor: 44.544
Authors: Tracy A Battaglia; Christine M Gunn; Molly E McCoy; Helen H Mu; Amy S Baranoski; Elizabeth Y Chiao; Lisa A Kachnic; Elizabeth A Stier Journal: Womens Health Issues Date: 2015-08-04
Authors: Gypsyamber D'Souza; Shirani D Rajan; Rohini Bhatia; Ross D Cranston; Michael W Plankey; Anthony Silvestre; David G Ostrow; Dorothy Wiley; Nisha Shah; Noel T Brewer Journal: Am J Public Health Date: 2013-07-18 Impact factor: 9.308